Cargando…
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study
Clinical trials demonstrated the role of vaccines and antiviral treatments against SARS-CoV-2 in reducing the likelihood of disease progression and death. However, there are limited data available regarding the time to negativity of people who received these treatments. Further, several comorbiditie...
Autores principales: | De Vito, Andrea, Moi, Giulia, Saderi, Laura, Puci, Mariangela V., Colpani, Agnese, Firino, Laura, Puggioni, Anna, Uzzau, Sergio, Babudieri, Sergio, Sotgiu, Giovanni, Madeddu, Giordano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675806/ https://www.ncbi.nlm.nih.gov/pubmed/38005858 http://dx.doi.org/10.3390/v15112180 |
Ejemplares similares
-
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression
por: De Vito, Andrea, et al.
Publicado: (2022) -
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era?
por: De Vito, Andrea, et al.
Publicado: (2023) -
Living with HIV and Getting Vaccinated: A Narrative Review
por: De Vito, Andrea, et al.
Publicado: (2023) -
Special Issue “Efficacy and Safety of Antiviral Therapy”
por: Colpani, Agnese, et al.
Publicado: (2023) -
Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free
por: Fiore, Vito, et al.
Publicado: (2022)